These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10417535)

  • 21. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.
    Bowszyc-Dmochowska M; Dmochowski M
    J Med; 2002; 33(1-4):189-98. PubMed ID: 12939118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
    Taghipour K; Kirtschig G; Palace J; Groves RW; Venning V; Wojnarowska F
    J Am Acad Dermatol; 2012 Jul; 67(1):160-1. PubMed ID: 22703914
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase in antigenicity of basement membrane zone antigens in bullous pemphigoid.
    Remy W
    J Invest Dermatol; 1986 Aug; 87(2):294-5. PubMed ID: 3525690
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
    Seishima M; Izumi T; Kitajima Y
    Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blistering insights into the pathogenesis of bullous pemphigoid.
    Wong HK; Bechtel MA
    Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
    [No Abstract]   [Full Text] [Related]  

  • 26. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract]   [Full Text] [Related]  

  • 27. A case of bullous pemphigoid with antidesmoplakin autoantibodies.
    Watanabe K; Hashimoto T; Ishiko A; Shimizu H; Nishikawa T
    Dermatology; 1994; 189 Suppl 1():126-8. PubMed ID: 8049553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bullous colon lesions in a patient with bullous pemphigoid.
    Sachsenberg-Studer EM; Runne U; Wehrmann T; Wolter M; Kriener S; Engels K; Elshorst-Schmidt T; Kaufmann R; Borradori L
    Gastrointest Endosc; 2001 Jul; 54(1):104-8. PubMed ID: 11427857
    [No Abstract]   [Full Text] [Related]  

  • 29. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
    Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunohistologic detection of bullous pemphigoid antigen in malignant melanoma].
    Hamm G; Reiss CJ
    Dermatol Monatsschr; 1985; 171(12):788-92. PubMed ID: 3912222
    [No Abstract]   [Full Text] [Related]  

  • 31. Bullous pemphigoid antigens.
    Diaz LA; Anhalt GJ; Hosokawa H; Takahashi Y
    Keio J Med; 1986 Jun; 35(2):69-79. PubMed ID: 3537434
    [No Abstract]   [Full Text] [Related]  

  • 32. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of KM genotype with bullous pemphigoid.
    Raux G; Gilbert D; Joly P; Daveau M; Martel P; Christ M; Tron F
    J Autoimmun; 2000 Feb; 14(1):79-82. PubMed ID: 10648118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
    Izumi H; Hosokawa H
    Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1).
    Peyron E; Nicolas JF; Réano A; Roche P; Thivolet J; Haftek M; Schmitt D; Péronne C; Banchereau J; Rousset F
    J Immunol; 1994 Aug; 153(3):1333-9. PubMed ID: 8027561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of paraneoplastic pemphigus and bullous pemphigoid.
    Kakurai M; Demitsu T; Iida E; Umemoto N; Yamada T; Yoneda K; Kako S; Ohshima K; Ohyama B; Hashimoto T
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):962-4. PubMed ID: 19207671
    [No Abstract]   [Full Text] [Related]  

  • 37. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Western blot analysis of the antigen in pemphigoid gestationis.
    Kelly SE; Bhogal BS; Wojnarowska F; Whitehead P; Leigh IM; Black MM
    Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
    Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
    Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
    [No Abstract]   [Full Text] [Related]  

  • 40. The immunopathology of bullous pemphigoid.
    Imber MJ; Murphy GF; Jordon RE
    Clin Dermatol; 1987; 5(1):81-92. PubMed ID: 3552196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.